Abstract Body

Background:

Recent French Perinatal Cohort data demonstrated no vertical transmissions among 5482 women living with HIV fulfilling the following criteria: effective ART from conception; undetectable plasma HIV RNA viral load (VL) near delivery; infant post-exposure prophylaxis (PEP); no breastfeeding. Despite fulfilling these criteria, we present two cases of vertical transmission from one UK centre and review the literature.

Methods:

Retrospective case series of two infant HIV infections, without known vertical transmission risks. Review of maternal and infant notes. Literature review for cases of HIV transmission despite undetectable maternal plasma HIV RNA.

Results:

Cases series. Both mothers conceived on triple ART. Excellent adherence reported. With an exception of 380 HIV RNA copies/ml (cpm) at gestational age (GA) 8 weeks in case A, both had multiple VL measures <50 cpm during pregnancy and around delivery (38 weeks GA for mother A; 36 weeks GA for mother B). Mother A had 6 weeks of enoxaparin from 11 weeks GA; mother B an iron infusion at 33 weeks GA. Both deliveries were term, one vaginal with induction of labour for pre-eclampsia at 38 weeks with <1 hour ruptured membranes, and one a planned pre-labour, pre-rupture of membranes Caesarean section at 39 weeks. Both infants had negative HIV VL at birth, had standard of care zidovudine PEP for 2–4 weeks as per contemporary guidelines and were exclusively formula-fed. HIV RNA was first detected in Infant A at 12 weeks (17.6 x 106 cpm) and in infant B at 6 weeks (1.4 x 106 cpm). Literature review. One late transmission reported in Dolphin-2: Efavirenz-based ART commenced week 28 GA with HIV VL undetectable at delivery, weeks 6, 12, 24, 48 and 72 post-partum. Exclusive breastfeeding to 24 weeks, breastmilk and solids to 48 weeks when breastfeeding stopped. The infant was HIV negative on VL testing until week 72. HIV sequencing and phylogenetic analyses linked all infant and maternal viruses.

Conclusions:

Without detectable maternal viraemia, vertical HIV transmission is rare. Residual transmission may be from cell-associated virus, the dominant mode of transmission for other human retroviruses. ART may limit cell-associated HIV transmission. Exposure to maternal ART in utero may act as foetal pre-exposure prophylaxis and infant PEP protects for a limited period postnatally. Maternal lymphocyte persistence in the infant circulation, whether transplacental or gut-absorption, with cell-associated transmission, is likely implicated in these rare cases.